Top

Gepubliceerd in:

10-09-2019

Psychometric properties of the PROMIS^® Fatigue Short Form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome

Auteurs: Manshu Yang, San Keller, Jin-Mann S. Lin

Gepubliceerd in: Quality of Life Research | Uitgave 12/2019

Abstract

Purpose

To evaluate the psychometric properties of the Patient-Reported Outcome Measurement Information System® Fatigue Short Form 7a (PROMIS F-SF) among people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Methods

Analyses were conducted using data from the Multi-Site Clinical Assessment of ME/CFS study, which recruited participants from seven ME/CFS specialty clinics across the US. Baseline and follow-up data from ME/CFS participants and healthy controls were used. Ceiling/Floor effects, internal consistency reliability, differential item functioning (DIF), known-groups validity, and responsiveness were examined.

Results

The final sample comprised 549 ME/CFS participants at baseline, 386 of whom also had follow-up. At baseline, the sample mean of PROMIS F-SF T-score was 68.6 (US general population mean T-score of 50 and standard deviation of 10). The PROMIS F-SF demonstrated good internal consistency reliability (Cronbach’s α = 0.84) and minimal floor/ceiling effects. No DIF was detected by age or sex for any item. This instrument also showed good known-groups validity with medium-to-large effect sizes (η² = 0.08–0.69), with a monotonic increase of the fatigue T-score across ME/CFS participant groups with low, medium, and high functional impairment as measured by three different variables (p < 0.01), and with significantly higher fatigue T-scores among ME/CFS participants than healthy controls (p < 0.0001). Acceptable responsiveness was found with small-to-medium effect sizes (Guyatt’s Responsiveness Statistic = 0.28–0.54).

Conclusions

Study findings support the reliability and validity of PROMIS F-SF as a measure of fatigue for ME/CFS and lend support to the drug development tool submission for qualifying this measure to evaluate therapeutic effect in ME/CFS clinical trials.

vorige artikel Development of a mental health recovery module for the WHOQOL

volgende artikel A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder

Clayton, E. W. (2015). Beyond myalgic encephalomyelitis/chronic fatigue syndrome: An IOM report on redefining an illness. JAMA,313(11), 1101–1102. https://doi.org/10.1001/jama.2015.1346.CrossRefPubMed

United States Food and Drug Administration. (2013). The voice of the patient: Chronic fatigue syndrome and myalgic encephalomyelitis. Bethesda: United States Food and Drug Administration.

Afari, N., & Buchwald, D. (2003). Chronic fatigue syndrome: A review. American Journal of Psychiatry,160(2), 221–236. https://doi.org/10.1176/appi.ajp.160.2.221.CrossRefPubMed

Jason, L. A., Richman, J. A., Rademaker, A. W., Jordan, K. M., Plioplys, A. V., Taylor, R. R., et al. (1999). A community-based study of chronic fatigue syndrome. Archives of Internal Medicine,159(18), 2129–2137.CrossRefPubMed

Reyes, M., Nisenbaum, R., Hoaglin, D. C., et al. (2003). Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Archives of Internal Medicine,163(13), 1530–1536. https://doi.org/10.1001/archinte.163.13.1530.CrossRefPubMed

Reeves, W. C., Jones, J. F., Maloney, E., Heim, C., Hoaglin, D. C., Boneva, R. S., et al. (2007). Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr,5, 5. https://doi.org/10.1186/1478-7954-5-5.CrossRefPubMedPubMedCentral

Lin, J. S., Resch, S. C., Brimmer, D. J., Johnson, A., Kennedy, S., Burstein, N., et al. (2011). The economic impact of chronic fatigue syndrome in Georgia: Direct and indirect costs. Cost Effectiveness and Resource Allocation,9(1), 1. https://doi.org/10.1186/1478-7547-9-1.CrossRefPubMedPubMedCentral

Reynolds, K. J., Vernon, S. D., Bouchery, E., & Reeves, W. C. (2004). The economic impact of chronic fatigue syndrome. Cost Effectiveness and Resource Allocation,2, 4. https://doi.org/10.1186/1478-7547-2-4.CrossRefPubMedPubMedCentral

Jason, L. A., Benton, M. C., Valentine, L., Johnson, A., & Torres-Harding, S. (2008). The economic impact of ME/CFS: Individual and societal costs. Dynamic Medicine,7, 6. https://doi.org/10.1186/1476-5918-7-6.CrossRefPubMedPubMedCentral

10.

Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study International. Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine,121(12), 953–959.CrossRefPubMed

11.

Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., et al. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Journla of Chronic Fatigue Syndrome,11(1), 7–115.CrossRef

12.

Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., et al. (2011). Myalgic encephalomyelitis: International consensus criteria. Journal of Internal Medicine,270(4), 327–338. https://doi.org/10.1111/j.1365-2796.2011.02428.x.CrossRefPubMedPubMedCentral

13.

Lai, J.-S., Cella, D., Choi, S., Junghaenel, D. U., Christodoulou, C., Gershon, R., et al. (2011). How item banks and their application can influence measurement practice in rehabilitation medicine: A PROMIS fatigue item bank example. Archives of Physical Medicine and Rehabilitation,92(10.0), S20–S27. https://doi.org/10.1016/j.apmr.2010.08.033.CrossRefPubMedPubMedCentral

14.

National Institutes of Health (2007). PROMIS domain framework/definitions. http://www.nihpromis.org/measures/domainframework.

15.

Smets, E. M. A., Garssen, B., Bonke, B., & De Haes, J. C. J. M. (1995). The Multidimensional Fatigue Inventory (MFI) Psychometric Qualities of an Instrument to Assess Fatigue. Journal of Psychosomatic Research,39(3), 315–325. https://doi.org/10.1016/0022-3999(94)00125-O.CrossRefPubMed

16.

Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., et al. (1993). Development of a fatigue scale. Journal of Psychosomatic Research,37(2), 147–153.CrossRefPubMed

17.

Khanna, D., Maranian, P., Rothrock, N., Cella, D., Gershon, R., Khanna, P. P., et al. (2012). Feasibility and construct validity of PROMIS and legacy Instruments in an Academic Scleroderma Clinic—Analysis from the UCLA Scleroderma Quality of Life Study. Value Health,15(1), 128–134. https://doi.org/10.1016/j.jval.2011.08.006.CrossRefPubMed

18.

US Department of Health and Human Services Food and Drug Administration. (2009). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims.

19.

Unger, E. R., Lin, J.-M. S., Tian, H., Natelson, B. H., Lange, G., Vu, D., et al. (2017). Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): Design and Implementation of a prospective/retrospective rolling cohort study. American Journal of Epidemiology,185(8), 617–626. https://doi.org/10.1093/aje/kwx029.CrossRefPubMed

20.

Bjorner, J. B., Rose, M., Gandek, B., Stone, A. A., Junghaenel, D. U., & Ware, J. E., Jr. (2014). Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. Journal of Clinical Epidemiology,67(1), 108–113. https://doi.org/10.1016/j.jclinepi.2013.07.016.CrossRefPubMedPubMedCentral

21.

Embretson, S. E., & Reise, S. P. (2013). Item response theory. Rotterdam: Psychology Press.CrossRef

22.

Liu, H., Cella, D., Gershon, R., Shen, J., Morales, L. S., Riley, W., et al. (2010). Representativeness of the PROMIS Internet Panel. Journal of Clinical Epidemiology,63(11), 1169–1178. https://doi.org/10.1016/j.jclinepi.2009.11.021.CrossRefPubMedPubMedCentral

23.

Cai, L., Thissen, D., & du Toit, S. H. C. (2011). IRTPRO: Flexible, multidimensional, multiple categorical IRT modeling. Lincolnwood, IL: Scientific Software International.

24.

SAS Institute Inc. (2002–2014). SAS®9.4 Help and Documentation. Cary, NC: SAS Institute Inc.

25.

Wang, L., Zhang, Z., McArdle, J. J., & Salthouse, T. A. (2009). Investigating ceiling effects in longitudinal data analysis. Multivariate Behav Res,43(3), 476–496. https://doi.org/10.1080/00273170802285941.CrossRefPubMedPubMedCentral

26.

Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires.,60(1), 34–42.

27.

Nunnally, J., & Bernstein, I. (1978). Psychometric Theory McGraw-Hill New York Google Scholar.

28.

Lohr, K N J Qo L R. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life,11(3), 193–205.CrossRef

29.

Bartlett, S. J., Orbai, A.-M., Duncan, T., DeLeon, E., Ruffing, V., Clegg-Smith, K., et al. (2015). Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS ONE,10(9), e0138543.CrossRefPubMedPubMedCentral

30.

Yost, K. J., Eton, D. T., Garcia, S. F., & Cella, D. J. J. O. C. E. (2011). Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. Journal of Clinical Epidemiology,64(5), 507–516.CrossRefPubMedPubMedCentral

31.

Lord, F. M. (1980). Applications of item response theory to practical testing problems. Hillsdale, NJ: Lawrence Erlbaum Associates.

32.

Langer, M. M. (2008). A Reexamination of Lord’s Wald Test for Differential Item Functioning Using Item Response Theory and Modern Error Estimation. Doctoral Dissertation, University of North Carolina at Chapel Hill.

33.

Rusu, C., Gee, M. E., Lagacé, C., & Parlor, M. (2015). Chronic fatigue syndrome and fibromyalgia in Canada: Prevalence and associations with six health status indicators. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice,35(1), 3–11.CrossRef

34.

Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological),57(1), 289–300.CrossRef

35.

Thissen, D., Steinberg, L., & Kuang, D. (2002). Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. Journal of Educational and Behavioral Statistics,27(1), 77–83. https://doi.org/10.3102/10769986027001077.CrossRef

36.

Tukey, J. W. (1949). Comparing individual means in the analysis of variance. Biometrics,5(2), 99–114. https://doi.org/10.2307/3001913.CrossRefPubMed

37.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.

38.

Miles, J., & Shevlin, M. (2001). Applying regression & correlation: A guide for students and researchers (1st ed.). Thousand Oaks, CA: Sage.

39.

Badhiwala, J. H., Witiw, C. D., Nassiri, F., Akbar, M. A., Jaja, B., Wilson, J. R., et al. (2018). Minimum clinically important difference in SF-36 scores for use in degenerative cervical myelopathy. Spine. https://doi.org/10.1097/brs.0000000000002684.CrossRefPubMed

40.

Swigris, J. J., Brown, K. K., Behr, J., du Bois, R. M., King, T. E., Raghu, G., et al. (2010). The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF. Respiratory Medicine,104(2), 296–304. https://doi.org/10.1016/j.rmed.2009.09.006.CrossRefPubMed

41.

Ward, M. M., Guthrie, L. C., & Alba, M. I. (2014). Clinically important chances in short form-36 scales for use in rheumatoid arthritis clinical trials: The impact of low responsiveness. Arthritis Care & Research,66(12), 1783–1789. https://doi.org/10.1002/acr.22392.CrossRef

42.

Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care,41(5), 582–592. https://doi.org/10.1097/01.mlr.0000062554.74615.4c.CrossRefPubMed

43.

Guyatt, G., Walter, S., & Norman, G. (1987). Measuring change over time: Assessing the usefulness of evaluative instruments. Journal of Chronic Diseases,40(2), 171–178. https://doi.org/10.1016/0021-9681(87)90069-5.CrossRefPubMed

44.

Cook, K. F., Bamer, A. M., Roddey, T. S., Kraft, G. H., Kim, J., & Amtmann, D. (2012). A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Quality of Life Research,21(6), 1021–1030. https://doi.org/10.1007/s11136-011-0011-8.CrossRefPubMed

45.

Ameringer, S., Elswick, R. K., Jr., Menzies, V., Robins, J. L., Starkweather, A., Walter, J., et al. (2016). Psychometric evaluation of the patient-reported outcomes measurement information system fatigue-short form across diverse populations. Nursing Research,65(4), 279–289. https://doi.org/10.1097/nnr.0000000000000162.CrossRefPubMedPubMedCentral

46.

DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A. (2007). Evaluation of item candidates: The PROMIS qualitative item review. Medical Care,45(5 Suppl 1), S12–S21. https://doi.org/10.1097/01.mlr.0000254567.79743.e2.CrossRefPubMedPubMedCentral

Titel: Psychometric properties of the PROMIS® Fatigue Short Form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome
Auteurs: Manshu Yang
San Keller
Jin-Mann S. Lin
Publicatiedatum: 10-09-2019
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 12/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02289-4

Andere artikelen Uitgave 12/2019

Health-related quality of life in adult population before and after the onset of financial crisis: the case of Athens, Greece

Positive associations of optimism–pessimism orientation with pro-environmental behavior and subjective well-being: a longitudinal study on quality of life and everyday behavior

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia

Open Access

Next of kin’s quality of life before and after implementation of a knowledge-based palliative care intervention in nursing homes

Open Access

A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review

Review